Target intelligence / Profile preview

U1 small nuclear ribonucleoprotein complex (U1 snRNP)

Target
U1 snRNP
Molecular classification
Ribonucleoprotein complex, Spliceosomal complex, RNA-binding protein complex
01

Overview

The U1 small nuclear ribonucleoprotein (U1 snRNP) complex is a major component of the spliceosome, the molecular machine responsible for removing introns from pre-mRNA [1, 4]. It is composed of the U1 small nuclear RNA (snRNA), a core of seven Sm proteins, and three specific proteins: U1-70K, U1A, and U1C [2, 4]. The primary function of U1 snRNP is to recognize and bind the 5' splice site of introns through base-pairing with the U1 snRNA, thereby initiating spliceosome assembly [4, 12]. Additionally, it plays a vital role in "telescripting," a process that prevents premature polyadenylation and ensures the transcription of long genes [1, 13]. Mutations or functional defects in U1 snRNP are implicated in neurodegenerative diseases such as Spinal Muscular Atrophy (SMA) and Amyotrophic Lateral Sclerosis (ALS), as well as in various cancers [3, 6, 14]. Therapeutically, U1 snRNP is targeted by small molecule splicing modulators like Risdiplam and Branaplam, which enhance its binding to specific splice sites to correct genetic defects [8, 9]. It is also a well-known autoantigen in systemic autoimmune diseases, where anti-U1 RNP antibodies serve as diagnostic markers [2].

Other names
U1 snRNPU1 ribonucleoproteinU1 small nuclear ribonucleoprotein particleU1 RNP
02

Mechanism of action

Splicing modulation by stabilizing the interaction between the U1 snRNP complex and the 5' splice site of pre-mRNA to promote exon inclusion.

03

Biological functions

Pre-mRNA splicingTelescriptingSuppression of premature polyadenylationRegulation of 3'-end processingTranscription regulation
04

Disease associations

Spinal Muscular AtrophyAmyotrophic Lateral SclerosisSystemic Lupus ErythematosusMixed Connective Tissue DiseaseCancerAlzheimer's disease
05

Safety considerations

Off-target splicing effectsGlobal splicing disruptionImmunogenicity and autoimmune reactions
06

Interacting drugs

Risdiplam

1 more in the full profile.

07

Biomarkers

Anti-U1 RNP antibodiesSMN2 exon 7 inclusionSMN protein levels

Beyond the preview

Go deeper on U1 small nuclear ribonucleoprotein complex (U1 snRNP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U1 small nuclear ribonucleoprotein complex (U1 snRNP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call